Analgesics
Antiandrogens
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Results
Abstract
All ivermectin studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19ivm.org COVID-19 treatment researchIvermectinIvermectin (more..)
Melatonin Meta
Metformin Meta
Azvudine Meta
Bromhexine Meta Molnupiravir Meta
Budesonide Meta
Colchicine Meta
Conv. Plasma Meta Nigella Sativa Meta
Curcumin Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   

Crying wolf in time of Corona: the strange case of ivermectin and hydroxychloroquine. Is the fear of failure withholding potential life-saving treatment from clinical use?

Nardelli et al., Signa Vitae, doi:10.22514/sv.2021.043
Mar 2021  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
Mortality 79% Improvement Relative Risk Ivermectin  Nardelli et al.  META ANALYSIS c19ivm.org Favorsivermectin Favorscontrol 0 0.5 1 1.5 2+
Ivermectin for COVID-19
4th treatment shown to reduce risk in August 2020
 
*, now with p < 0.00000000001 from 104 studies, recognized in 22 countries.
No treatment is 100% effective. Protocols combine treatments. * >10% efficacy, ≥3 studies.
4,300+ studies for 75 treatments. c19ivm.org
Meta analysis of RCT mortality results showing RR 0.19, p < 0.00001.
7 meta analyses show significant improvements with ivermectin for mortality1-6, hospitalization7, recovery3, and cases3.
Currently there are 104 ivermectin for COVID-19 studies, showing 48% lower mortality [35‑59%], 35% lower ventilation [17‑50%], 40% lower ICU admission [12‑58%], 34% lower hospitalization [21‑44%], and 81% fewer cases [71‑87%].
risk of death, 79.5% lower, RR 0.21, p < 0.001, treatment 14 of 703 (2.0%), control 57 of 620 (9.2%), NNT 14, odds ratio converted to relative risk.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Nardelli et al., 11 Mar 2021, peer-reviewed, 8 authors.
This PaperIvermectinAll
{ 'indexed': {'date-parts': [[2022, 4, 5]], 'date-time': '2022-04-05T20:15:11Z', 'timestamp': 1649189711123}, 'reference-count': 0, 'publisher': 'MRE Press', 'content-domain': {'domain': [], 'crossmark-restriction': False}, 'published-print': {'date-parts': [[2021]]}, 'DOI': '10.22514/sv.2021.043', 'type': 'journal-article', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T05:41:24Z', 'timestamp': 1615527684000}, 'source': 'Crossref', 'is-referenced-by-count': 2, 'title': 'Crying wolf in time of Corona: the strange case of ivermectin and hydroxychloroquine. Is the ' 'fear of failure withholding potential life-saving treatment from clinical use?', 'prefix': '10.22514', 'member': '26027', 'published-online': {'date-parts': [[2021]]}, 'container-title': 'Signa Vitae', 'original-title': [], 'link': [ { 'URL': 'https://oss.signavitae.com/mre-signavitae/article/20210508-344/pdf/3-4%20SV2021022602.pdf', 'content-type': 'unspecified', 'content-version': 'vor', 'intended-application': 'similarity-checking'}], 'deposited': { 'date-parts': [[2022, 2, 24]], 'date-time': '2022-02-24T19:35:58Z', 'timestamp': 1645731358000}, 'score': 1, 'resource': {'primary': {'URL': 'https://www.signavitae.com/articles/10.22514/sv.2021.043'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2021]]}, 'references-count': 0, 'URL': 'http://dx.doi.org/10.22514/sv.2021.043', 'relation': {}, 'subject': [], 'container-title-short': 'SV', 'published': {'date-parts': [[2021]]}}
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit